Fourth COVID-19 booster supercharges antibody defense in older adults, study says

The study finds that the fourth dose of the COVID-19 mRNA vaccine significantly boosts neutralizing antibody levels in the elderly, providing enhanced protection against new SARS-CoV-2 variants like Omicron. This supports the efficacy of booster shots for older populations in combating COVID-19.

MSD’s Keytruda and Eisai’s Lenvima fail in Phase III uterine cancer trial

Share this article The combination therapy of MSD’s Keytuda and Eisai’s Lenvima are being evaluated as part of a LEAP clinical programme. Image Credit: Poetra.RH

December 8, 2023

What Will New Weight-Loss Drugs Mean for Endometrial Cancer?

Obesity has been recognized as an endometrial cancer risk factor since at least the 1960s and remains the single most impactful risk factor for the

June 8, 2024

Otsuka pens AAV deal with Shape Therapeutics for eye gene therapies

Japanese pharmaceutical company Otsuka has enlisted Seattle-based RNA editing biotech Shape Therapeutics to develop new adeno-associated virus (AAV) vectors. The hope is to find new ways

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.